Oil Is the New Gold
Health Care: Drugs
PDL BioPharma Inc. (PDLI: NASDAQ)
$7.69 -0.23 | -2.90%
06/19/13 - 04:00 PM ET
Insider Trading
| Historical Data | Current | 1 Mo. Ago | 2 Mo. Ago | 3 Mo. Ago | 4 Mo. Ago | 5 Mo. Ago | 6 Mo. Ago |
|---|---|---|---|---|---|---|---|
| Net Insider Transaction | 38,524 | 50,863 | 50,863 | 50,863 | 0 | 0 | 0 |
| Shares Bought | 38,524 | 50,863 | 50,863 | 50,863 | 0 | 0 | 0 |
| Shares Sold | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Institutional Trading
| Historical Data | Current | 1 Mo. Ago | 2 Mo. Ago | 3 Mo. Ago | 4 Mo. Ago | 5 Mo. Ago | 6 Mo. Ago |
|---|---|---|---|---|---|---|---|
| Total Shares Held | 129.28M | 129.11M | 152.52M | 151.24M | 153.01M | 141.32M | 127.12M |
| Shares Bought | 14.55M | 14.56M | 28.63M | 26.70M | 25.84M | 31.14M | 17.02M |
| Shares Sold | 14.16M | 13.88M | 22.40M | 21.67M | 22.74M | 26.35M | 26.41M |
Portfolios with PDLI
- Portfolio NameUser Type
- ProHighbridge Capital Management
- ContributorEarnings Short Squeeze Play...
- UserSm. Magic July 5 13
- UserMy Stuff
- Userdgr008 Portfolio 1
- ContributorHighest-Yielding Drug Stocks
- UserDividend
- Contributor18 Fundamentally Strong Sto...
- UserGK13
- UserMy current
Latest PDLI Headlines from TheStreet
- PDL BioPharma (PDLI) Shares Cross Below 200 DMA 04.17.13 | 12:04 pm
- 5 Buy-Rated Dividend Stocks 04.16.13 | 11:04 am
- 3 Buy-Rated Dividend Stocks 04.04.13 | 11:04 am
- 2 Drug Stocks Under $10 To Pick As Favorites 03.25.13 | 02:03 pm
- 'Mad Money' Lightning Round: Stay Away From Intel 11.06.12 | 06:11 am
- Cramer's 'Mad Money' Recap: Politics Is Overrated 11.05.12 | 08:11 pm
- PDL BioPharma Inc. Stock Upgraded (PDLI) 10.19.12 | 05:10 am
- Cramer's 'Mad Money' Recap: Next Week's Game Plan 09.28.12 | 08:09 pm
- PDL BioPharma's CEO Discusses Q2 2012 Results - Earnings Call Transcript 08.04.12 | 12:08 am
- 5 Hated Stocks Set to Soar on Earnings 07.10.12 | 11:07 am
Press Releases for PDLI
- PDL BioPharma Completes Regular Quarterly Dividend Payment - PR Newswire 06.12.13 | 04:06 pm
- PDL Files For Arbitration Against Genentech Based On Underpayment Of Royalties - PR Newswire 06.11.13 | 07:06 am
- PDL BioPharma Announces Conversion Rate Adjustments For Convertible Notes - PR Newswire 06.03.13 | 04:06 pm
- PDL BioPharma To Present At Upcoming Investor Conferences - PR Newswire 05.30.13 | 07:05 am
- PDL BioPharma To Announce First Quarter 2013 Financial Results On May 9, 2013 - PR Newswire 05.02.13 | 07:05 am
- PDL BioPharma Appoints Peter Garcia As Chief Financial Officer - PR Newswire 04.30.13 | 04:04 pm
- PDL BioPharma Completes Structured Financing And Royalty Transaction With Avinger - PR Newswire 04.22.13 | 12:04 pm
- PDL BioPharma Completes Regular Quarterly Dividend Payment - PR Newswire 03.12.13 | 04:03 pm
- PDL BioPharma To Hold Annual Meeting Of Stockholders On May 21, 2013 - PR Newswire 03.06.13 | 04:03 pm
- PDL BioPharma Announces Conversion Rate Adjustments For Convertible Notes - PR Newswire 03.04.13 | 07:03 am
Partner Headlines for PDLI
- PDL BioPharma, Inc. (PDLI) Ex-Dividend Date Scheduled for June 03, 2013 - NASDAQ 05.31.13 | 01:05 pm
- 10 Sharp Healthcare Dogs Diagnose 7.4% To 62.1% Gains In March - Seeking Alpha 04.01.13 | 09:04 am
- After-Hours Earnings Report for March 1, 2013 : VNR, PDLI - NASDAQ 03.01.13 | 07:03 pm
- PDL BioPharma, Inc. (PDLI) Ex-Dividend Date Scheduled for March 01, 2013 - NASDAQ 02.27.13 | 02:02 pm
- 8 High-Yielding Dividend Stocks With Very Low PEG Ratios - Seeking Alpha 12.30.12 | 09:12 am
- PDL BioPharma, AxoGen Benefit From 'Royal' Agreement - Seeking Alpha 11.20.12 | 09:11 am
- UPDATE: Credit Suisse Initiates PDL Biopharma at Neutral on Dividend Continuity Questions - Benzinga 11.13.12 | 01:11 pm
- These 2 Cramer High-Yield Picks Are Worth Buying In The Market Pullback - Seeking Alpha 11.08.12 | 09:11 am
- Cramer's Lightning Round - Heckmann Is Still A Good Spec (9/28/12) - Seeking Alpha 09.30.12 | 07:09 am
- PDLI Guides Q3 Royalty Rev to $85M - Analyst Blog - NASDAQ 09.07.12 | 08:09 pm
